Extract from the Register of European Patents

EP About this file: EP0594729

EP0594729 - 2-(4-HYDROXYPIPERIDINO)-1-ALKANOL DERIVATIVES AS ANTIISCHEMIC AGENTS [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  10.11.2000
Database last updated on 28.03.2026
Most recent event   Tooltip10.11.2000Refusal of applicationpublished on 27.12.2000 [2000/52]
Applicant(s)For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
[N/P]
Former [1994/18]For all designated states
PFIZER INC.
235 East 42nd Street
New York, N.Y. 10017 / US
Inventor(s)01 / WELCH, Willard, McKowan, Jr.
116 Pequot Avenue
Mystic, CT 06355 / US
[1994/18]
Representative(s)Moore, James William, et al
Pfizer Limited Ramsgate Road Sandwich
Kent CT13 9NJ / GB
[N/P]
Former [1994/18]Moore, James William, Dr., et al
Pfizer Limited Ramsgate Road
Sandwich Kent CT13 9NJ / GB
Application number, filing date92915510.919.06.1992
[1994/18]
WO1992US04973
Priority number, dateUS1991073157717.07.1991         Original published format: US 731577
[1994/18]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9302052
Date:04.02.1993
Language:EN
[1993/04]
Type: A1 Application with search report 
No.:EP0594729
Date:04.05.1994
Language:EN
The application published by WIPO in one of the EPO official languages on 04.02.1993 takes the place of the publication of the European patent application.
[1994/18]
Search report(s)International search report - published on:EP04.02.1993
ClassificationIPC:C07D211/48, C07D211/44, C07D401/06, A61K31/445
[1994/18]
CPC:
C07D401/06 (EP); A61P25/00 (EP); A61P25/28 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1994/18]
TitleGerman:2-(4-HYDROXYPIPERIDINO)-1-ALKANOLDERIVATE ALS ANTI-ISCHÄMISCHE WIRKSTOFFE[1994/18]
English:2-(4-HYDROXYPIPERIDINO)-1-ALKANOL DERIVATIVES AS ANTIISCHEMIC AGENTS[1994/18]
French:DERIVES 2-(4-HYDROXYPIPERIDINO)-1-ALCANOL UTILISES COMME AGENTS ANTI-ISCHEMIQUES[1994/18]
Entry into regional phase10.01.1994National basic fee paid 
10.01.1994Designation fee(s) paid 
10.01.1994Examination fee paid 
Examination procedure09.11.1992Request for preliminary examination filed
International Preliminary Examining Authority: EP
10.01.1994Examination requested  [1994/18]
29.07.1994Despatch of a communication from the examining division (Time limit: M04)
25.10.1994Reply to a communication from the examining division
03.09.1996Despatch of a communication from the examining division (Time limit: M04)
12.11.1996Reply to a communication from the examining division
30.03.1999Despatch of a communication from the examining division (Time limit: M04)
14.05.1999Reply to a communication from the examining division
25.02.2000Despatch of communication of intention to grant (Approval: )
03.08.2000Despatch of communication that the application is refused, reason: formalities examination [2000/52]
13.08.2000Application refused, date of legal effect [2000/52]
Fees paidRenewal fee
19.04.1994Renewal fee patent year 03
16.03.1995Renewal fee patent year 04
27.03.1996Renewal fee patent year 05
10.04.1997Renewal fee patent year 06
09.04.1998Renewal fee patent year 07
10.04.1999Renewal fee patent year 08
10.03.2000Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.